4.6 Review

Mitochondrial Diseases: A Diagnostic Revolution

期刊

TRENDS IN GENETICS
卷 36, 期 9, 页码 702-717

出版社

CELL PRESS
DOI: 10.1016/j.tig.2020.06.009

关键词

-

资金

  1. MRC Mitochondrial Biology Unit [MC_UU_00015/9]
  2. MRC International Centre for Genomic Medicine in Neuromuscular Disease [MR/S005021/1]
  3. Leverhulme Trust [RPG-2018-408]
  4. MRC [MR/S035699/1, MR/N025431/1]
  5. Alzheimer's Society [AS-PG-18b-022]
  6. NIHR Biomedical Research Centre based at Cambridge University Hospitals National Health Service (NHS) Foundation Trust
  7. University of Cambridge
  8. Addenbrooke's Charitable Trust
  9. Newton Fund [MR/N027302/1]
  10. Wellcome Investigator Fund [109915/Z/15/Z]
  11. Lily Foundation UK
  12. European Research Council [309548]
  13. Wellcome Trust Pathfinder Scheme [201064/Z/16/Z]
  14. MRC [MR/S035699/1, MC_UU_00015/10, MC_UU_00015/9] Funding Source: UKRI

向作者/读者索取更多资源

Mitochondrial disorders have emerged as a common cause of inherited disease, but are traditionally viewed as being difficult to diagnose clinically, and even more difficult to comprehensively characterize at the molecular level. However, new sequencing approaches, particularly whole-genome sequencing (WGS), have dramatically changed the landscape. The combined analysis of nuclear and mitochondrial DNA (mtDNA) allows rapid diagnosis for the vast majority of patients, but new challenges have emerged. We review recent discoveries that will benefit patients and families, and highlight emerging questions that remain to be resolved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据